| Laura B Hughes, MD | |
|
2000 Pepperell Pkwy, Opelika, AL 36801-5452 | |
| (334) 528-6610 | |
| (334) 528-6628 |
| Full Name | Laura B Hughes |
|---|---|
| Gender | Female |
| Speciality | Rheumatology |
| Experience | 28 Years |
| Location | 2000 Pepperell Pkwy, Opelika, Alabama |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598792178 | NPI | - | NPPES |
| 051518470 | Other | AL | BLUE CROSS |
| 009942095 | Medicaid | AL | |
| 051518470 | Medicaid | AL | |
| 051518471 | Other | AL | BLUE CROSS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RR0500X | Internal Medicine - Rheumatology | 23191 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| East Alabama Medical Center And Snf | Opelika, AL | Hospital |
| Russell Medical Center | Alexander city, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The East Alabama Health Care Authority | 3072403237 | 81 |
News Archive
SuperNova Diagnostics, a privately-held global diagnostics company for human and non-human health applications, announced today that it has signed an agreement with Shenzhen Kang Sheng Bao Bio-Technology, a biotechnology diagnostics company specializing in research, manufacture and distribution of in-vitro diagnostic kits and research reagents in China and affiliated markets for the research, development, manufacture and commercialisation of diagnostic products and services for the measurement of Neopterin, its metabolites and derivatives utilising the SuperNova technology platform of AmpCrystal.
The mechanistic association between migraines and type 2 diabetes reveals a new approach to treat diabetes.
Virginia Commonwealth University has received a five-year, $3 million grant to study how adverse experiences such as severe illnesses, neglect and maltreatment during childhood leave molecular marks in DNA that predict health risks later in life.
For the first time, scientists from the Florida campus of The Scripps Research Institute have identified small molecules that allow for complete control over a genetic defect responsible for the most common adult onset form of muscular dystrophy.
› Verified 4 days ago
| Entity Name | University Of Alabama Health Services Foundation, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093768723 PECOS PAC ID: 1951213107 Enrollment ID: O20031105000261 |
News Archive
SuperNova Diagnostics, a privately-held global diagnostics company for human and non-human health applications, announced today that it has signed an agreement with Shenzhen Kang Sheng Bao Bio-Technology, a biotechnology diagnostics company specializing in research, manufacture and distribution of in-vitro diagnostic kits and research reagents in China and affiliated markets for the research, development, manufacture and commercialisation of diagnostic products and services for the measurement of Neopterin, its metabolites and derivatives utilising the SuperNova technology platform of AmpCrystal.
The mechanistic association between migraines and type 2 diabetes reveals a new approach to treat diabetes.
Virginia Commonwealth University has received a five-year, $3 million grant to study how adverse experiences such as severe illnesses, neglect and maltreatment during childhood leave molecular marks in DNA that predict health risks later in life.
For the first time, scientists from the Florida campus of The Scripps Research Institute have identified small molecules that allow for complete control over a genetic defect responsible for the most common adult onset form of muscular dystrophy.
› Verified 4 days ago
| Entity Name | The East Alabama Health Care Authority |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073685483 PECOS PAC ID: 3072403237 Enrollment ID: O20040824001092 |
News Archive
SuperNova Diagnostics, a privately-held global diagnostics company for human and non-human health applications, announced today that it has signed an agreement with Shenzhen Kang Sheng Bao Bio-Technology, a biotechnology diagnostics company specializing in research, manufacture and distribution of in-vitro diagnostic kits and research reagents in China and affiliated markets for the research, development, manufacture and commercialisation of diagnostic products and services for the measurement of Neopterin, its metabolites and derivatives utilising the SuperNova technology platform of AmpCrystal.
The mechanistic association between migraines and type 2 diabetes reveals a new approach to treat diabetes.
Virginia Commonwealth University has received a five-year, $3 million grant to study how adverse experiences such as severe illnesses, neglect and maltreatment during childhood leave molecular marks in DNA that predict health risks later in life.
For the first time, scientists from the Florida campus of The Scripps Research Institute have identified small molecules that allow for complete control over a genetic defect responsible for the most common adult onset form of muscular dystrophy.
› Verified 4 days ago
| Entity Name | Cooper Green Mercy Health Services Authority An Affiliate Of Uab |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366073108 PECOS PAC ID: 0840629473 Enrollment ID: O20200402003238 |
News Archive
SuperNova Diagnostics, a privately-held global diagnostics company for human and non-human health applications, announced today that it has signed an agreement with Shenzhen Kang Sheng Bao Bio-Technology, a biotechnology diagnostics company specializing in research, manufacture and distribution of in-vitro diagnostic kits and research reagents in China and affiliated markets for the research, development, manufacture and commercialisation of diagnostic products and services for the measurement of Neopterin, its metabolites and derivatives utilising the SuperNova technology platform of AmpCrystal.
The mechanistic association between migraines and type 2 diabetes reveals a new approach to treat diabetes.
Virginia Commonwealth University has received a five-year, $3 million grant to study how adverse experiences such as severe illnesses, neglect and maltreatment during childhood leave molecular marks in DNA that predict health risks later in life.
For the first time, scientists from the Florida campus of The Scripps Research Institute have identified small molecules that allow for complete control over a genetic defect responsible for the most common adult onset form of muscular dystrophy.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Laura B Hughes, MD 2000 Pepperell Pkwy, Opelika, AL 36801-5452 Ph: (334) 528-6610 | Laura B Hughes, MD 2000 Pepperell Pkwy, Opelika, AL 36801-5452 Ph: (334) 528-6610 |
News Archive
SuperNova Diagnostics, a privately-held global diagnostics company for human and non-human health applications, announced today that it has signed an agreement with Shenzhen Kang Sheng Bao Bio-Technology, a biotechnology diagnostics company specializing in research, manufacture and distribution of in-vitro diagnostic kits and research reagents in China and affiliated markets for the research, development, manufacture and commercialisation of diagnostic products and services for the measurement of Neopterin, its metabolites and derivatives utilising the SuperNova technology platform of AmpCrystal.
The mechanistic association between migraines and type 2 diabetes reveals a new approach to treat diabetes.
Virginia Commonwealth University has received a five-year, $3 million grant to study how adverse experiences such as severe illnesses, neglect and maltreatment during childhood leave molecular marks in DNA that predict health risks later in life.
For the first time, scientists from the Florida campus of The Scripps Research Institute have identified small molecules that allow for complete control over a genetic defect responsible for the most common adult onset form of muscular dystrophy.
› Verified 4 days ago
Amanda Elizabeth Austin, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 121 N 20th St Ste 6, Opelika, AL 36801 Phone: 334-705-3322 | |
Charles J Diskin, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 2609 Village Professional Dr, Suite 3, Opelika, AL 36801 Phone: 334-749-6523 Fax: 334-742-0242 | |
Dr. Kevin P Ryan, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 2601 Village Professional Dr N, Opelika, AL 36801 Phone: 334-528-5400 Fax: 334-528-5421 | |
Thomas Jefferson Stokes Jr., MD Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 2609 Village Professional Dr, Suite 3, Opelika, AL 36801 Phone: 334-749-6523 Fax: 334-742-0242 | |
Dr. George Gregory Gilbert, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 121 N 20th St, #6, Opelika, AL 36801 Phone: 334-949-3385 Fax: 334-742-9243 | |
Dr. William P Mcgehee, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 121 N 20th St, #6, Opelika, AL 36801 Phone: 334-749-3385 Fax: 334-749-3385 | |
Joseph Rogers Downs Iii, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 121 N 20th St Ste 20b, Opelika, AL 36801 Phone: 334-321-3700 Fax: 334-887-7475 |